drugset / Trial / NCT06942104
Imaging of Solid Tumors Using 18F-TRX
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors. Diagnostic procedures, such as 18F-TRX PET/CT or PET/MRI, may help detect tumors in patients with solid tumors
Timeline
- Start
- 2025-07-03
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-TRX | Diagnostic / imaging agent | — | Intravenous |